Uniseed is a venture fund that invests in innovative technologies emerging from Australian universities and research organizations.

Uniseed

Uniseed is Australia’s longest-running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and investment partners including a leading Australian Superannuation Fund, UniSuper.

We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.

QRxPharma

Smart Sparrow

Spinifex Pharmaceuticals

BT Imaging

Fibrotech Therapeutics

Fultec Semiconductor

Congratulations to Kinoxis Therapeutics Pty Ltd on the successful completion of your Series B capital raise! 

Uniseed are proud to be among the key investors supporting this important milestone, which raised an impressive $14.5 million. This funding will be instrumental in advancing your Phase 2 programs for KNX100, a groundbreaking treatment addressing the behavioral and psychological symptoms of dementia and substance use disorders. 

We look forward to witnessing the positive impact of your work, and all the great things you'll accomplish next.

John Kurek Liza Yeo Katrina Sorocos David Markwell Ross Macdonald Mary C Frey Geoff Waring Aoife Cullen Kathryn Sunn Taylor Syme Harikesh Pushpapathan Eric Xiaojia Wei Brigitte Smith

Congratulations to Hugh Alsop, CEO of Uniseed investee company Kinoxis Therapeutics Pty Ltd who won the CEO of the Year award at The Brooker Prize gala last week.

This prestigious industry award recognises Hugh's 20+ years of leadership and outstanding contributions within the Australian life sciences sector.  

Congratulations, Hugh!

Uniseed is excited to have invested in Diraq, a spin-out from UNSW developing a quantum computer to be manufactured using standard semiconductor manufacturing equipment and materials.

Colin D. Dax Kukulj David Woollard Cherie van Wensveen Leong Mar Michael Angliss Danielle Neale MBA GAICD Geoff Waring Kyle Giumelli Paul Butler Jeffrey Bourne Laura Droessler-Dansie

Congratulations to BioScout on winning the "Best in Horticulture" award at the Australian Agritech Association Awards!

Congratulations to Helen Souris and the Cardihab team on this significant achievement and partnership!

Want to find out what it takes to receive external funding to help commercialise your technology? Join Uniseed's Investment Manager Laura Droessler-Dansie for tomorrow's early-stage funding webinar!

msh id	COM:UNISEED
symbol	-
name	Uniseed
homepage url	https://uniseed.com
country	AU
sector	Financial Services & Finance
industry	Venture Capital
market	PRIVATE
employee count	22
crunchbase url	-
linkedin url	https://www.linkedin.com/company/uniseed
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

UNIS

COM:UNISEED

Uniseed

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-